FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Corbett

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Anatomy

Tumor Cells, Cultured

Concepts & Ideas

Structure-Activity Relationship

Co-author Network

Publications

TOP 3
Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Thomas H Corbett; Jerome P Horwitz
Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5.
Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Thomas H Corbett; Jerome P Horwitz
Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4.
Jian Liang; Richard E Moore; Eric D Moher; John E Munroe; Rima S Al-Awar; David A Hay; David L Varie; Tony Y Zhang; James A Aikins; Michael J Martinelli; Chuan Shih; James E Ray; Lowell L Gibson; Vasu Vasudevan; Lisa Anne Polin ; Kathryn White; Juiwanna Kushner; Chiab Simpson; Susan Pugh; Thomas H Corbett
Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Corbett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Thomas H Corbett; Jerome P Horwitz
Synthesis and biological evaluation of conformationally constrained analogs of the antitumor agents XK469 and SH80. Part 5.
Bioorganic & medicinal chemistry 2006;14(7):2462-7.
2005: Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Thomas H Corbett; Jerome P Horwitz
Synthetic modification of the 2-oxypropionic acid moiety in 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469), and consequent antitumor effects. Part 4.
Bioorganic & medicinal chemistry 2005;13(12):3910-20.
2005: Jian Liang; Richard E Moore; Eric D Moher; John E Munroe; Rima S Al-Awar; David A Hay; David L Varie; Tony Y Zhang; James A Aikins; Michael J Martinelli; Chuan Shih; James E Ray; Lowell L Gibson; Vasu Vasudevan; Lisa Anne Polin ; Kathryn White; Juiwanna Kushner; Chiab Simpson; Susan Pugh; Thomas H Corbett
Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Investigational new drugs 2005;23(3):213-24.
2005: Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Thomas H Corbett; Jason Biehl; Jerome P Horwitz
Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid.
Bioorganic & medicinal chemistry 2005;13(4):1069-81.
2004: Rima S Al-Awar; Thomas H Corbett; James E Ray; Lisa Anne Polin ; joseph kennedy; Margaret M Wagner; Daniel C Williams
Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Molecular cancer therapeutics 2004;3(9):1061-7.
2004: Jeffrey L Evelhoch; Patricia M LoRusso; Zhanquan He; Zachary DelProposto; Lisa Anne Polin ; Thomas H Corbett; Peter Langmuir; Catherine Wheeler; Andrew Stone; Joanna Leadbetter; Anderson Ryan; David C Blakey; John C Waterton
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3650-7.
2003: Yuxiang Zhang; Marcia I Dawson; Yangmin Ning; Lisa Anne Polin ; Ralph E Parchment; Thomas H Corbett; Anwar N Mohamed; Kai-Chia Feng; Lulu Farhana; Arun K Rishi; Donna Hogge; Mark Leid; Valerie J Peterson; Xiao-kun Zhang; Ramzi M Mohammad; Jin-Song Lu; Cheryl L Willman; Eric VanBuren; Sandra Biggar; Mark Edelstein; David Eilender; Joseph A Fontana
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
Blood 2003;102(10):3743-52.
2003: Rima S Al-Awar; James E Ray; Richard M Schultz; Sherri L Andis; joseph kennedy; Richard E Moore; Jian Liang; Trimurtulu Golakoti; Gottumukkala V Subbaraju; Thomas H Corbett
A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Journal of medicinal chemistry 2003;46(14):2985-3007.
2003: Ramesh R Boinpally; Lisa Anne Polin ; Sen-Lin Zhou; Bhaskara R Jasti; Richard A Wiegand; Kathryn White; Juiwanna Kushner; Jerome P Horwitz; Thomas H Corbett; Ralph E Parchment
Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
Cancer chemotherapy and pharmacology 2003;52(1):25-33.
2003: Susan Mooberry; Rachel M Leal; Tina L Tinley; Hendrik Luesch; Richard E Moore; Thomas H Corbett
The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.
International journal of cancer. Journal international du cancer 2003;104(4):512-21.
2003: Thomas H Corbett; Kathryn White; Lisa Anne Polin ; Juiwanna Kushner; Jennifer Paluch; Chuan Shih; Cora Sue Grossman
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.
Investigational new drugs 2003;21(1):33-45.
2002: Ruifang Wang; Thomas H Corbett; Yung-Chi Cheng; John C Drach; Earl R Kern; Hiroaki Mitsuya; Jiri Zemlicka
Tryptophanyl phosphoramidates as prodrugs of synadenol and its E-isomer: synthesis and biological activity.
Bioorganic & medicinal chemistry letters 2002;12(17):2467-70.
2002: Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Kathryn White; Nicole M Bouregeois; Brianna Crantz; Eduardo Palomino; Thomas H Corbett; Jerome P Horwitz
II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
Journal of medicinal chemistry 2002;45(14):3130-7.
2002: Srinivasu Poondru; Ralph E Parchment; Vivek Purohit; Patricia M LoRusso; Jerome P Horwitz; Stuart T Hazeldine; Lisa Anne Polin ; Thomas H Corbett; Bhaskara R Jasti
Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.
Investigational new drugs 2002;20(1):23-33.
2002: Lisa Anne Polin ; Kathryn White; Juiwanna Kushner; Jennifer Paluch; Chiab Simpson; Susan Pugh; Mark Edelstein; Stuart T Hazeldine; Joseph A Fontana; Patricia M LoRusso; Jerome P Horwitz; Thomas H Corbett
Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice.
Investigational new drugs 2002;20(1):13-22.
2002: Hendrik Luesch; Wesley Y Yoshida; Richard E Moore; Valerie J Paul; Susan Mooberry; Thomas H Corbett
Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.
Journal of natural products 2002;65(1):16-20.
2001: Ruifang Wang; Mohamad Ksebati; Thomas H Corbett; Earl R Kern; John C Drach; Jiri Zemlicka
Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity.
Journal of medicinal chemistry 2001;44(23):4019-22.
2001: Srinivasu Poondru; S Zhou; JB Rake; Gareth Shackleton; Thomas H Corbett; Ralph E Parchment; Bhaskara R Jasti
High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.
Journal of chromatography. B, Biomedical sciences and applications 2001;759(1):175-8.
2001: Hendrik Luesch; Richard E Moore; Valerie J Paul; Susan Mooberry; Thomas H Corbett
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
Journal of natural products 2001;64(7):907-10.
2001: Hendrik Luesch; Wesley Y Yoshida; Richard E Moore; Valerie J Paul; Thomas H Corbett
Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.
Journal of the American Chemical Society 2001;123(23):5418-23.
2001: Stuart T Hazeldine; Lisa Anne Polin ; Juiwanna Kushner; Jennifer Paluch; Kathryn White; Mark Edelstein; Eduardo Palomino; Thomas H Corbett; Jerome P Horwitz
Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
Journal of medicinal chemistry 2001;44(11):1758-76.
2000: Patricia M LoRusso; Brenda J Foster; Antoinette J Wozniak; Lance K Heilbrun; J I McCormick; P E Ruble; Martin A Graham; Jeremy Purvis; JB Rake; M Drozd; Graham F Lockwood; Thomas H Corbett
Phase I pharmacokinetic study of the novel antitumor agent SR233377.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3088-94.
1999: D L Varie; Chuan Shih; D A Hay; Sherri L Andis; Thomas H Corbett; LS Gossett; S K Janisse; Michael J Martinelli; Eric D Moher; Richard M Schultz; JE Toth
Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
Bioorganic & medicinal chemistry letters 1999;9(3):369-74.
1999: Chuan Shih; LS Gossett; Joseph M Gruber; Cora Sue Grossman; Sherri L Andis; Richard M Schultz; JF Worzalla; Thomas H Corbett; J T Metz
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region.
Bioorganic & medicinal chemistry letters 1999;9(1):69-74.
1999: Thomas H Corbett; C Panchapor; Lisa Anne Polin ; N Lowichik; Susan Pugh; Kathryn White; Juiwanna Kushner; J Meyer; J Czarnecki; S Chinnukroh; Mark Edelstein; Patricia M LoRusso; Lance K Heilbrun; Jerome P Horwitz; Charles K Grieshaber; RB Perni; MP Wentland; S Coughlin; S Elenbaas; R Philion; JB Rake
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin.
Investigational new drugs 1999;17(1):17-27.
1998: George G Harrigan; Wesley Y Yoshida; Richard E Moore; Dale G Nagle; PU Park; J Biggs; Valerie J Paul; Susan Mooberry; Thomas H Corbett; Frederick A Valeriote
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.
Journal of natural products 1998;61(10):1221-5.
1998: RB Perni; MP Wentland; J I Huang; R G Powles; S Aldous; K M Klingbeil; A D Peverly; R G Robinson; Thomas H Corbett; J L Jones; K C Mattes; JB Rake; S A Coughlin
Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
Journal of medicinal chemistry 1998;41(19):3645-54.
1998: George G Harrigan; Hendrik Luesch; Wesley Y Yoshida; Richard E Moore; Dale G Nagle; Valerie J Paul; Susan Mooberry; Thomas H Corbett; Frederick A Valeriote
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
Journal of natural products 1998;61(9):1075-7.
1998: S Sperry; Frederick A Valeriote; Thomas H Corbett; Phillip Crews
Isolation and cytotoxic evaluation of marine sponge-derived norterpene peroxides.
Journal of natural products 1998;61(2):241-7.
1998: Patricia M LoRusso; Ralph E Parchment; LL Demchik; J Knight; Lisa Anne Polin ; J Dzubow; C Behrens; B Harrison; George L Trainor; Thomas H Corbett
Preclinical antitumor activity of XK469 (NSC 656889).
Investigational new drugs 1998;16(4):287-96.
1998: Thomas H Corbett; Patricia M LoRusso; L Demchick; Chiab Simpson; Susan Pugh; Kathryn White; Juiwanna Kushner; Lisa Anne Polin ; J Meyer; J Czarnecki; Lance K Heilbrun; Jerome P Horwitz; J L Gross; C H Behrens; B A Harrison; R J McRipley; George L Trainor
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate.
Investigational new drugs 1998;16(2):129-39.
1998: Frederick A Valeriote; Thomas H Corbett; P A Grieco; Eric D Moher; J L Collins; T J Fleck
Anticancer activity of glaucarubinone analogues.
Oncology research 1998;10(4):201-8.
1998: Mark Edelstein; Thomas H Corbett; Frederick A Valeriote
In vitro screening model for the detection of agents active against myelogenous leukemia.
Cancer investigation 1998;16(5):303-8.
1997: Brenda J Foster; Richard A Wiegand; Susan Pugh; Patricia M LoRusso; JB Rake; Thomas H Corbett
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):2047-53.
1997: Thomas H Corbett; Frederick A Valeriote; LL Demchik; N Lowichik; Lisa Anne Polin ; C Panchapor; Susan Pugh; Kathryn White; Juiwanna Kushner; JB Rake; MP Wentland; Trimurtulu Golakoti; C Hetzel; J Ogino; G Patterson; R Moore
Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice.
Investigational new drugs 1997;15(3):207-18.
1997: Brenda J Foster; L Jones; Richard A Wiegand; Patricia M LoRusso; Thomas H Corbett
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline).
Investigational new drugs 1997;15(3):187-94.
1997: Lisa Anne Polin ; Frederick A Valeriote; Kathryn White; C Panchapor; Susan Pugh; J Knight; Patricia M LoRusso; Maha Hussain; E Liversidge; N Peltier; Trimurtulu Golakoti; G Patterson; R Moore; Thomas H Corbett
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice.
Investigational new drugs 1997;15(2):99-108.
1996: Thomas H Corbett; Frederick A Valeriote; LL Demchik; Lisa Anne Polin ; C Panchapor; Susan Pugh; Kathryn White; J Knight; J Jones; L Jones; Patricia M LoRusso; Brenda J Foster; Richard A Wiegand; L Lisow; Trimurtulu Golakoti; C E Heltzel; J Ogino; G M Patterson; Richard E Moore
Preclinical anticancer activity of cryptophycin-8.
Journal of experimental therapeutics & oncology 1996;1(2):95-108.
1996: E Merisko-Liversidge; P Sarpotdar; J Bruno; S Hajj; L Wei; N Peltier; JB Rake; J M Shaw; S Pugh; Lisa Anne Polin ; J Jones; Thomas H Corbett; E Cooper; G G Liversidge
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.
Pharmaceutical research 1996;13(2):272-8.
1996: Patricia M LoRusso; LL Demchik; Brenda J Foster; J Knight; MC Bissery; Lisa Anne Polin ; Wilbur R Leopold; Thomas H Corbett
Preclinical antitumor activity of CI-994.
Investigational new drugs 1996;14(4):349-56.
1996: Eduardo Palomino; Brenda J Foster; M Kempff; Thomas H Corbett; Richard A Wiegand; Jerome P Horwitz; Laurence H Baker
Identification and antitumor activity of a reduction product in the murine metabolism of pyrazoloacridine (NSC-366140).
Cancer chemotherapy and pharmacology 1996;38(5):453-8.
1996: Frederick A Valeriote; Thomas H Corbett; Mark Edelstein; Laurence H Baker
New in vitro screening model for the discovery of antileukemic anticancer agents.
Cancer investigation 1996;14(2):124-41.
1995: Nicholas H. Oberlies; J L Jones; Thomas H Corbett; S S Fotopoulos; JL McLaughlin
Tumor cell growth inhibition by several Annonaceous acetogenins in an in vitro disk diffusion assay.
Cancer letters 1995;96(1):55-62.
1995: S A Coughlin; D W Danz; R G Robinson; K M Klingbeil; MP Wentland; Thomas H Corbett; W R Waud; Leonard A Zwelling; E Altschuler; E Bales
Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161).
Biochemical pharmacology 1995;50(1):111-22.
1995: Patricia M LoRusso; LL Demchik; M Dan; Lisa Anne Polin ; J L Gross; Thomas H Corbett
Comparative efficacy of DMP 840 against mouse and human solid tumor models.
Investigational new drugs 1995;13(3):195-203.
1995: Zora Djuric Longworth; Thomas H Corbett; Frederick A Valeriote; Lance K Heilbrun; Laurence H Baker
Detoxification ability and toxicity of quinones in mouse and human tumor cell lines used for anticancer drug screening.
Cancer chemotherapy and pharmacology 1995;36(1):20-6.
1994: Jerome P Horwitz; I Massova; T E Wiese; B H Besler; Thomas H Corbett
Comparative molecular field analysis of the antitumor activity of 9H-thioxanthen-9-one derivatives against pancreatic ductal carcinoma 03.
Journal of medicinal chemistry 1994;37(6):781-6.
1993: Jerome P Horwitz; I Massova; T E Wiese; Antoinette J Wozniak; Thomas H Corbett; Judith Leopold; D B Capps; Wilbur R Leopold
Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
Journal of medicinal chemistry 1993;36(23):3511-6.
1992: E A Poplin; Thomas H Corbett; Lawrence E Flaherty; P Tarasoff; Bruce G Redman; Manuel Valdivieso; Laurence H Baker
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
Investigational new drugs 1992;10(3):165-70.
1991: W Negendank; Thomas H Corbett; M Crowley; C Kellogg
Evidence for a contribution of paramagnetic ions to water proton spin-lattice relaxation in normal and malignant mouse tissues.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1991;18(2):280-93.
1991: S Phadtare; David Kessel; Thomas H Corbett; H E Renis; B A Court; J Zimlicka
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
Journal of medicinal chemistry 1991;34(1):421-9.
1990: Patricia M LoRusso; S L Aukerman; Lisa Anne Polin ; Bruce G Redman; Manuel Valdivieso; L Biernat; Thomas H Corbett
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.
Cancer research 1990;50(18):5876-82.
1990: Patricia M LoRusso; Antoinette J Wozniak; Lisa Anne Polin ; D Capps; Wilbur R Leopold; L M Werbel; L Biernat; M E Dan; Thomas H Corbett
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
Cancer research 1990;50(16):4900-5.
1990: S S Neelam; A Bernabei; C Freedland; R Thompson; Thomas H Corbett; GD Luk
Combination of flavone acetic acid (FAA) with adriamycin, cis-platinum and difluoromethylornithine (DFMO) in vitro against human colon cancer cells.
Investigational new drugs 1990;8(3):263-8.
1990: P Mucci-LoRusso; Lisa Anne Polin ; L A Biernat; Frederick A Valeriote; Thomas H Corbett
Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.
Investigational new drugs 1990;8(3):253-61.
1990: W De Neve; Jeffrey L Evelhoch; C Everett; N Simpson; MC Bissery; Thomas H Corbett; Frederick A Valeriote
Interaction between flavone acetic acid (LM-975, NSC 349512) and radiation in Glasgow's osteogenic sarcoma in vivo.
International journal of radiation oncology, biology, physics 1990;18(6):1359-65.
1990: W DeNeve; Frederick A Valeriote; E Tapazoglou; C Everett; A Khatana; Thomas H Corbett
Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo.
Investigational new drugs 1990;8(1):17-24.
1990: W G Negendank; L E McCoy; M G Crowley; Thomas H Corbett; E L Schmidt
In vitro measurement of tissue vascular space by 19F NMR of a perfluorocarbon blood substitute.
Biomaterials, artificial cells, and artificial organs 1990;18(1):119-23.
1990: J Brodfuehrer; Frederick A Valeriote; K Chan; Lance K Heilbrun; Thomas H Corbett
Flavone acetic acid and plasma protein binding.
Cancer chemotherapy and pharmacology 1990;27(1):27-32.
1989: P Mucci-LoRusso; Lisa Anne Polin ; MC Bissery; Frederick A Valeriote; J Plowman; GD Luk; Thomas H Corbett
Activity of batracylin (NSC-320846) against solid tumors of mice.
Investigational new drugs 1989;7(4):295-306.
1989: Thomas H Corbett; MC Bissery; P Mucci-LoRusso; Lisa Anne Polin
5-Fluorouracil containing combinations in murine tumor systems.
Investigational new drugs 1989;7(1):37-49.
1989: Guy G. Chabot; MC Bissery; Thomas H Corbett; K Rutkowski; Laurence H Baker
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
Cancer chemotherapy and pharmacology 1989;24(1):15-22.
1988: E Tapazoglou; Lisa Anne Polin ; Thomas H Corbett; M al-Sarraf
Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.
Investigational new drugs 1988;6(4):259-64.
1988: Jeffrey L Evelhoch; MC Bissery; Guy G. Chabot; N E Simpson; C L McCoy; Lance K Heilbrun; Thomas H Corbett
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
Cancer research 1988;48(17):4749-55.
1988: JD Crissman; Richard J Zarbo; C D Niebylski; Thomas H Corbett; Donald Willard Weaver
Flow cytometric DNA analysis of colon adenocarcinomas: a comparative study of preparatory techniques.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1988;1(3):198-204.
1988: MC Bissery; Frederick A Valeriote; Guy G. Chabot; JD Crissman; C Yost; Thomas H Corbett
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo.
Cancer research 1988;48(5):1279-85.
1987: Sam C Brooks; Jerome P Horwitz; D Odden; Thomas H Corbett
A-ring substituted estrogens as inhibitors of the MXT transplantable mammary ductal carcinoma.
Cancer research 1987;47(17):4623-9.
1987: John F Ensley; Z Maciorowski; H Pietraszkiewicz; G Klemic; M KuKuruga; S Sapareto; Thomas H Corbett; JD Crissman
Solid tumor preparation for flow cytometry using a standard murine model.
Cytometry 1987;8(5):479-87.
1987: R Pazdur; Bruce G Redman; Thomas H Corbett; M Phillips; Laurence H Baker
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.
Cancer research 1987;47(15):4213-7.
1987: Wilbur R Leopold; Thomas H Corbett; D P Griswold; J Plowman; B C Baguley
Experimental antitumor activity of the amsacrine analogue CI-921.
Journal of the National Cancer Institute 1987;79(2):343-9.
1987: Jeffrey L Evelhoch; N A Keller; Thomas H Corbett
Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas.
Cancer research 1987;47(13):3396-401.
1987: Peter J O'Dwyer; D Shoemaker; D S Zaharko; C Grieshaber; J Plowman; Thomas H Corbett; Frederick A Valeriote; S A King; J Cradock; D F Hoth
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.
Cancer chemotherapy and pharmacology 1987;19(1):6-10.
1987: J W Banning; Hanley N Abramson; Henry C Wormser; J D Wu; Thomas H Corbett
Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides.
Cancer chemotherapy and pharmacology 1987;19(3):207-12.
1987: Thomas H Corbett; Frederick A Valeriote; Laurence H Baker
Is the P388 murine tumor no longer adequate as a drug discovery model?
Investigational new drugs 1987;5(1):3-20.
1986: Thomas H Corbett; MC Bissery; Antoinette J Wozniak; J Plowman; Lisa Anne Polin ; E Tapazoglou; J Dieckman; Frederick A Valeriote
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
Investigational new drugs 1986;4(3):207-20.
1985: David Kessel; Thomas H Corbett
Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice.
Cancer letters 1985;28(2):187-93.
1985: J P Nachtman; E T Roginski; J W Banning; Henry C Wormser; Hanley N Abramson; Thomas H Corbett
DNA binding, cardiac superoxide production and cytotoxicity of daunomycin analogs.
Research communications in chemical pathology and pharmacology 1985;47(1):73-83.
1984: F M Schabel; D P Griswold; Thomas H Corbett; W R Laster
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.
Cancer 1984;54(6 Suppl):1160-7.
1984: Thomas H Corbett; Billy J Roberts; Wilbur R Leopold; J C Peckham; L J Wilkoff; D P Griswold; F M Schabel
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
Cancer research 1984;44(2):717-26.
1983: F M Schabel; Thomas H Corbett; D P Griswold; W R Laster; M W Trader
Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
Cancer treatment reviews 1983;10 Suppl B():13-21.
1983: F M Schabel; H E Skipper; M W Trader; W R Laster; D P Griswold; Thomas H Corbett
Establishment of cross-resistance profiles for new agents.
Cancer treatment reports 1983;67(10):905-22.
1983: Robert F Struck; D J Dykes; Thomas H Corbett; W J Suling; M W Trader
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
British journal of cancer 1983;47(1):15-26.
1983: W T Evanochko; T C Ng; M B Lilly; A J Lawson; Thomas H Corbett; J R Durant; Jerry D Glickson
In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(2):334-8.
1983: F M Schabel; D P Griswold; Thomas H Corbett; W R Laster
Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.
Pharmacology & therapeutics 1983;20(2):283-305.
1982: W T Evanochko; T C Ng; Jerry D Glickson; J R Durant; Thomas H Corbett
Human tumors as examined by in vivo 31P NMR in athymic mice.
Biochemical and biophysical research communications 1982;109(4):1346-52.
1982: Thomas H Corbett; Billy J Roberts; M W Trader; W R Laster; D P Griswold; F M Schabel
Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.
Cancer treatment reports 1982;66(5):1187-200.
1982: Thomas H Corbett; Wilbur R Leopold; D J Dykes; Billy J Roberts; D P Griswold; F M Schabel
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).
Cancer research 1982;42(5):1707-15.
1982: CP Spears; A H Shahinian; R G Moran; C Heidelberger; Thomas H Corbett
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Cancer research 1982;42(2):450-6.
1982: F M Schabel; H E Skipper; M W Trader; R W Brockman; W R Laster; Thomas H Corbett; D P Griswold
Drug control of Ara-C-resistant tumor cells.
Medical and pediatric oncology 1982;10 Suppl 1():125-48.
1981: D P Griswold; Thomas H Corbett; F M Schabel
Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.
Cancer treatment reports 1981;65 Suppl 2():51-4.
1981: Thomas H Corbett
Carcinogenesis.
International anesthesiology clinics 1981;19(4):99-120.
1981: Thomas H Corbett; D P Griswold; Billy J Roberts; F M Schabel
Absence of delayed lethality in mice treated with aclacinomycin A.
Cancer chemotherapy and pharmacology 1981;6(2):161-8.
1980: L Simpson-Herren; Thomas H Corbett; D P Griswold
The cell population kinetics and response to an S-phase specific agent of three transplantable colon tumor lines.
Cell and tissue kinetics 1980;13(6):613-24.
1980: F M Schabel; Thomas H Corbett; F M Schabel
Cell kinetics and the chemotherapy of murine solid tumors.
Antibiotics and chemotherapy 1980;28():28-34.
1980: F M Schabel; H E Skipper; M W Trader; W R Laster; Thomas H Corbett; D P Griswold
Concepts for controlling drug-resistant tumor cells.
European journal of cancer 1980;Suppl 1():199-211.
1979: F M Schabel; M W Trader; W R Laster; Thomas H Corbett; D P Griswold
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
Cancer treatment reports 1979;63(9-10):1459-73.
1979: Thomas H Corbett; D P Griswold; M K Wolpert; J M Venditti; F M Schabel
Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
Cancer treatment reports 1979;63(5):799-801.
1979: Thomas H Corbett
Pharmacology and toxicology of halogenated anesthetics.
Advances in pharmacology and chemotherapy 1979;16():195-212.
1978: Thomas H Corbett; D P Griswold; B J Roberts; J C Peckham; F M Schabel
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
Cancer treatment reports 1978;62(10):1471-88.
1978: B J Roberts; W P Fife; Thomas H Corbett; F M Schabel
Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen.
Cancer treatment reports 1978;62(7):1077-9.
1978: L Simpson-Herren; D P Griswold; Thomas H Corbett
Studies of the growth, population kinetics, and host lethality of CD8F mammary adenocarcinoma.
Cancer treatment reports 1978;62(4):519-28.
1978: Thomas H Corbett; J L Simmons; H Kawanishi; J L Endres
EM changes and other toxic effects of firemaster BP-6 (polybrominated biphenyls) in the mouse.
Environmental health perspectives 1978;23():275-81.
1977: Thomas H Corbett; D P Griswold; B J Roberts; J C Peckham; F M Schabel
Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas.
Cancer 1977;40(5 Suppl):2660-80.
1977: B P Sanl; Thomas H Corbett
Retinoic acid-binding protein in normal tissues and experimental tumors.
Cancer research 1977;37(1):209-13.
1976: Thomas H Corbett
O.R. exposure--cancer, miscarriages, and birth defects.
Women & health 1976;1(5):11-4.
1976: Thomas H Corbett
Cancer and congenital anomalies associated with anesthetics.
Annals of the New York Academy of Sciences 1976;271():58-66.
1975: D P Griswold; Thomas H Corbett
A colon tumor model for anticancer agent evaluation.
Cancer 1975;36(6 Suppl):2441-4.
1975: Thomas H Corbett; D P Griswold; B J Roberts; J C Peckham; F M Schabel
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.
Cancer research 1975;35(9):2434-9.
1975: Thomas H Corbett; D P Griswold; J G Mayo; W R Laster; F M Schabel
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Cancer research 1975;35(6):1568-73.
1974: Thomas H Corbett; P Nettesheim
Separation of multiple forms of protein-bound metabolites of the carcinogenic hydrocarbons 3-methylcholanthrene and 7,12-dimethylbenz(a)anthracene from several rodent species.
Chemico-biological interactions 1974;8(5):285-96.
1973: Thomas H Corbett; P Nettesheim
Effect of PR-8 viral respiratory infection of benz[a]pyrene hydroxylase activity in BALB/c mice.
Journal of the National Cancer Institute 1973;50(3):779-82.
1970: Thomas H Corbett; C Heidelberger; W F Dove
Determination of the mutagenic activity to bacteriophage T4 of carcinogenic and noncarcinogenic compounds.
Molecular pharmacology 1970;6(6):667-79.